Quick Takeaways
- 3i, LP filed SCHEDULE 13G/A for CNBX Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (CNBX).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
3i, LP - 31 Dec 2025 SCHEDULE 13G/A Report for CNBX Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (CNBX)
- Filing Manager
- 3i, LP
- Reporting Manager
- 3i, LP
- Symbol
- CNBX
- Shares outstanding
- 844,399,404 shares
- Disclosed Ownership
- 83,595,541 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2026, 16:07:01 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 10 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"3i, LP disclosed 9.9% ownership in CNBX Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (CNBX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 10 Nov 2025.
- Current filing was accepted on 05 Feb 2026, 16:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 3i, LP | 9.9% | 83,595,541 | 0 | 83,595,541 | /s/ 3i, LP | Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP | |
| 3i Management LLC | 9.9% | 83,595,541 | 0 | 83,595,541 | /s/ 3i Management LLC | Maier Joshua Tarlow, Manager | |
| Maier Joshua Tarlow | 9.9% | 83,595,541 | 0 | 83,595,541 | /s/ Maier Joshua Tarlow | Maier Joshua Tarlow |